The identification of more PAIS cases carrying a FKBP4 mutation will provide stronger confirmation for its implication in an androgen insensitivity phenotype and could contribute to the diagnosis of AIS patients lacking AR mutations. The gene discussed is AR; the disease is androgen insensitivity syndrome.